Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Femoral Lengthening Might Impair Physical Function and Lead to Structural Changes in Adjacent Joints; 10 Patients With 27 to 34 Years Follow-up.

NCT03966573 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT03966573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03966573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Femoral Lengthening Might Impair Physical Function and Lead to Structural Changes in Adjacent Joints; 10 Patients With 27 to 34 Years Follow-up.
Lead sponsor
Oslo University Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 6, 2019
Completion date
October 11, 2019
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leg length inequality, leg; lengthening, osteoarthritis of hip, osteoarthritis, knee, quality of life